MoneyWorks4Me

Aarti Pharmalabs informs about disclosure

15 May 2023 Evaluate

Further to letter dated May 12, 2023, wherein the company had submitted the Related Party Transactions for the half year ended March 31, 2023 with the Exchanges. The transactions regarding remuneration paid to the Key Managerial Personnel of the Company were inadvertently excluded in its original filing. Accordingly, Aarti Pharmalabs has updated the said transaction details in the enclosed disclosure document.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..